Pentoxifylline
- Generic Name
- Pentoxifylline
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C13H18N4O3
- CAS Number
- 6493-05-6
- Unique Ingredient Identifier
- SD6QCT3TSU
- Background
Pentoxifylline (PTX) is a synthetic dimethylxanthine derivative that modulates the rheological properties of blood and also has both anti-oxidant and anti-inflammatory properties. Although originally developed to treat intermittent claudication, a form of exertion-induced leg pain common in patients with peripheral arterial disease, PTX has been investigated...
- Indication
Pentoxifylline is indicated for the treatment of intermittent claudication in patients with chronic occlusive arterial disease. Pentoxifylline may improve limb function and reduce symptoms but cannot replace other therapies such as surgical bypass or removal of vascular obstructions.
- Associated Conditions
- Intermittent Claudication, Venous Leg Ulcer (VLU), Severe alcoholic liver disease
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.